These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31348936)

  • 1. α
    Koh B; Park SB; Yoon E; Yoo HM; Lee D; Heo JN; Ahn S
    J Pharm Sci; 2019 Nov; 108(11):3704-3712. PubMed ID: 31348936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma.
    Redko B; Tuchinsky H; Segal T; Tobi D; Luboshits G; Ashur-Fabian O; Pinhasov A; Gerlitz G; Gellerman G
    Oncotarget; 2017 Jan; 8(1):757-768. PubMed ID: 27768593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RGD peptide-based non-viral gene delivery vectors targeting integrin α
    Fu S; Xu X; Ma Y; Zhang S; Zhang S
    J Drug Target; 2019 Jan; 27(1):1-11. PubMed ID: 29564914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging.
    Liu S
    Mol Pharm; 2006; 3(5):472-87. PubMed ID: 17009846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenesis activities of novel peptide complexes: mitochondria-disruptive 9mer peptides conjugated with the integrin alpha V beta 3-homing cyclic RGD motif.
    Iwasaki T; Yamakawa M; Asaoka A; Kawano T; Ishibashi J
    Biosci Biotechnol Biochem; 2012; 76(11):2044-8. PubMed ID: 23132564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature.
    Liu Z; Jia B; Shi J; Jin X; Zhao H; Li F; Liu S; Wang F
    Bioconjug Chem; 2010 Mar; 21(3):548-55. PubMed ID: 20184307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
    Sun LC; Luo J; Mackey LV; Fuselier JA; Coy DH
    Cancer Lett; 2007 Feb; 246(1-2):157-66. PubMed ID: 16644105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
    He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
    Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.
    Shan D; Li J; Cai P; Prasad P; Liu F; Rauth AM; Wu XY
    Drug Deliv Transl Res; 2015 Feb; 5(1):15-26. PubMed ID: 25787336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects.
    Song Z; Lin Y; Zhang X; Feng C; Lu Y; Gao Y; Dong C
    Int J Nanomedicine; 2017; 12():1941-1958. PubMed ID: 28331317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel multifunctional poly(amidoamine) dendrimeric delivery system with superior encapsulation capacity for targeted delivery of the chemotherapy drug 10-hydroxycamptothecin.
    Kong X; Yu K; Yu M; Feng Y; Wang J; Li M; Chen Z; He M; Guo R; Tian R; Li Y; Wu W; Hong Z
    Int J Pharm; 2014 Apr; 465(1-2):378-87. PubMed ID: 24530519
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Siitonen R; Peuhu E; Autio A; Liljenbäck H; Mattila E; Metsälä O; Käkelä M; Saanijoki T; Dijkgraaf I; Jalkanen S; Ivaska J; Roivainen A
    J Nucl Med; 2019 Oct; 60(10):1380-1387. PubMed ID: 30850498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for the targeted binding of RGD-containing peptide to integrin αVβ3.
    Yu YP; Wang Q; Liu YC; Xie Y
    Biomaterials; 2014 Feb; 35(5):1667-75. PubMed ID: 24268666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cyclic-RGD-BioShuttle functionalized with TMZ by DARinv "Click Chemistry" targeted to αvβ3 integrin for therapy.
    Braun K; Wiessler M; Pipkorn R; Ehemann V; Bäuerle T; Fleischhacker H; Müller G; Lorenz P; Waldeck W
    Int J Med Sci; 2010 Sep; 7(6):326-39. PubMed ID: 20922134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligands for mapping alphavbeta3-integrin expression in vivo.
    Schottelius M; Laufer B; Kessler H; Wester HJ
    Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery.
    Gilad Y; Noy E; Senderowitz H; Albeck A; Firer MA; Gellerman G
    Bioorg Med Chem; 2016 Jan; 24(2):294-303. PubMed ID: 26719208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrac-conjugated polymersomes for integrin-targeted delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
    Alibolandi M; Rezvani R; Farzad SA; Taghdisi SM; Abnous K; Ramezani M
    Int J Pharm; 2017 Oct; 532(1):581-594. PubMed ID: 28935257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic-RGDyC functionalized liposomes for dual-targeting of tumor vasculature and cancer cells in glioblastoma: An in vitro boron neutron capture therapy study.
    Kang W; Svirskis D; Sarojini V; McGregor AL; Bevitt J; Wu Z
    Oncotarget; 2017 May; 8(22):36614-36627. PubMed ID: 28402271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting efficiency of RGD-modified nanocarriers with different ligand intervals in response to integrin αvβ3 clustering.
    Guo Z; He B; Jin H; Zhang H; Dai W; Zhang L; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
    Biomaterials; 2014 Jul; 35(23):6106-17. PubMed ID: 24794924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis In Vivo.
    Hu Q; Wang XY; Kang LK; Wei HM; Xu CM; Wang T; Wen ZH
    PLoS One; 2016; 11(2):e0149075. PubMed ID: 26862757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.